Education

Background

Dr. Eugenia Broude is Professor Emeritus of Drug Discovery and Biomedical Sciences at the University of South Carolina College of Pharmacy, having retired in January 2026. She joined the College of Pharmacy in 2011 as a member of the SmartState Center for Translational Cancer Therapeutics and became the first woman to be promoted to full professor in the college’s history.

Originally from Kyiv, Ukraine, Broude earned her Ph.D. in biochemistry and molecular biology from the Ukrainian Academy of Sciences and completed a postdoctoral fellowship in molecular biology and neuroscience at the National Institute of Child Health and Human Development at the National Institutes of Health.

Dr. Broude's research focused on understanding molecular mechanisms underlying cancer biology and treatment response, particularly the effects of anticancer drugs on tumor cells and factors that contribute to drug resistance and metastasis. Her work aimed to identify and analyze novel drug targets and strategies to improve the efficacy of existing cancer therapies, with a special interest in overcoming resistance in breast and ovarian cancers.

Throughout her tenure at USC, Dr. Broude was a prolific contributor to translational cancer research and a mentor to students involved in advanced research training. Her laboratory findings have informed clinical trials designed to improve treatment for patients with metastatic hormone receptor–positive breast cancer, marking significant progress in bridging basic science and clinical application.

Dr. Broude’s excellence in research was recognized by the College of Pharmacy with the Established Researcher Award in 2024.